iktos

📍 Paris, France🗓 Founded 2016👥 85 employees💰 Last funded Jan 2023
Biotechnology🌐 iktos.ai
Website LinkedIn
We are Iktos. A start-up company specializing in the development of proprietary artificial intelligence technologies and software for ligand-based and structure-based de novo drug design focusing on multi parametric optimization. Our de novo design algorithm is based on deep generative models with reinforcement learning. It designs novel and easy to make compounds, optimized to meet a given multi-objective blueprint, with unprecedented speed, performance, and diversity. Please visit our webpage to know more about our products and offerings https://iktos.ai/products/
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in iktos?
iktos has 1 investors on record on gritt.io and 1 late-stage investors.
When did iktos last raise funding?
The most recent investment in iktos recorded on gritt.io was in January 2023.
When was iktos founded?
iktos was founded in 2016.
What industry is iktos in?
iktos operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is iktos based?
iktos is headquartered in Paris, France.